Current status of diagnosing and treating thoracic solid tumors in Chinese children

References:

[1] Pusiol T, Piscioli I, Scialpi M, et al.Giant benign solitary fibrous tumour of the pleura (>15 cm):role of radiological pathological correlations in management.Report of 3 cases and review of the literature[J].Pathologica, 2013, 105(3):77-82.
[2] Guo N, Yu C, Liu Y, et al.Analysis of 50 cases of operated giant thoracic tumors[J].J BUON, 2015, 20(5):1360-1367.
[3] 叶木杰, 柳龚堡, 董岿然.CAR-T细胞免疫靶向治疗在儿童恶性肿瘤中的应用进展[J].中华小儿外科杂志, 2019, 40(4):370-373.DOI:10.3760/cma.j.issn.0253-3006.2019.04.017.Ye MJ, Liu GB, Dong KR.Advances of CAR-T cell immunotherapeutic targeting for malignant tumors of children[J].Chinese Journal of Pediatric Surgery, 2019, 40(4):370-373.DOI:10.3760/cma.j.issn.0253-3006.2019.04.017.
[4] 肖卉.神经母细胞瘤肿瘤微环境和免疫治疗的研究进展[J].国际儿科学杂志, 2021, 48(7):435-439.DOI:10.3760/cma.j.issn.1673-4408.2021.07.001. Xiao Hui.Tumor microenvironment and immunotherapy of neuroblastoma[J].International Journal of Pediatrics, 2021, 48(7):435-439.DOI:10.3760/cma.j.issn.1673-4408.2021.07.001.
[5] La Quaglia MP.Chest wall tumors in childhood and adolescence[J].Semin Pediatr Surg, 2008, 17(3):173-180.DOI:10.1053/j.sempedsurg.2008.03.007.
[6] Cipriano A, Burfeind W, Jr.Management of primary soft tissue tumors of the chest wall[J].Thorac Surg Clin, 2017, 27(2):139-147.DOI:10.1016/j.thorsurg.2017.01.007.
[7] Van Den Berg H, Van Rijn RR, Merks JH.Management of tumors of the chest wall in childhood:a review[J].J Pediatr Hematol Oncol, 2008, 30(3):214-221.DOI:10.1097/MPH.0b013e318162bd54.
[8] Ito T, Suzuki H, Yoshino I.Mini review:surgical management of primary chest wall tumors[J].Gen Thorac Cardiovasc Surg, 2016, 64(12):707-714.DOI:10.1007/s11748-016-0719-z.
[9] Grunewald TGP, Cidre-Aranaz F, Surdez D, et al.Ewing sarcoma[J].Nat Rev Dis Primers, 2018, 4(1):5.DOI:10.1038/s41572-018-0003-x.
[10] Gargallo P, Juan A, Yanez Y, et al.Precision medicine in Ewing sarcoma:a translational point of view[J].Clin Transl Oncol, 2020, 22(9):1440-1454.DOI:10.1007/s12094-020-02298-7.
[11] Yu H, Ge Y, Guo L, et al.Potential approaches to the treatment of Ewing’s sarcoma[J].Oncotarget, 2017, 8(3):5523-5539.DOI:10.18632/oncotarget.12566.
[12] Flores G, Grohar PJ.One oncogene, several vulnerabilities:EWS/FLI targeted therapies for Ewing sarcoma[J].J Bone Oncol, 2021, 31:100404.DOI:10.1016/j.jbo.2021.100404.
[13] Yohe ME, Heske CM, Stewart E, et al.Insights into pediatric rhabdomyosarcoma research:Challenges and goals[J].Pediatr Blood Cancer, 2019, 66(10):e27869.DOI:10.1002/pbc.27869.
[14] Leiner J, Le Loarer F.The current landscape of rhabdomyosarcomas:an update[J].Virchows Arch, 2020, 476(1):97-108.DOI:10.1007/s00428-019-02676-9.
[15] Mandeville HC.Radiotherapy in the management of childhood rhabdomyosarcoma[J].Clin Oncol (R Coll Radiol), 2019, 31(7):462-470.DOI:10.1016/j.clon.2019.03.047.
[16] Rogers TN, Dasgupta R.Management of rhabdomyosarcoma in pediatric patients[J].Surg Oncol Clin N Am, 2021, 30(2):339-353.DOI:10.1016/j.soc.2020.11.003.
[17] Skapek SX, Ferrari A, Gupta AA, et al.Rhabdomyosarcoma[J].Nat Rev Dis Primers, 2019, 5(1):1.DOI:10.1038/s41572-018-0051-2.
[18] Lichtenberger JP 3rd, Biko DM, Carter BW, et al.Primary lung tumors in children:radiologic-pathologic correlation from the Radiologic Pathology Archives[J].Radiographics, 2018, 38(7):2151-2172.DOI:10.1148/rg.2018180192.
[19] Weldon CB, Shamberger RC.Pediatric pulmonary tumors:primary and metastatic[J].Semin Pediatr Surg, 2008, 17(1):17-29.DOI:10.1053/j.sempedsurg.2007.10.004.
[20] Zapala MA, Ho-Fung VM, Lee EY.Thoracic neoplasms in children:contemporary perspectives and imaging assessment[J].Radiol Clin North Am, 2017, 55(4):657-676.DOI:10.1016/j.rcl.2017.02.008.
[21] Mahajan P, Casanova M, Ferrari A, et al.Inflammatory myofibroblastic tumor:molecular landscape, targeted therapeutics, and remaining challenges[J].Curr Probl Cancer, 2021, 45(4):100768.DOI:10.1016/j.currproblcancer.2021.100768.
[22] Casanova M, Brennan B, Alaggio R, et al.Inflammatory myofibroblastic tumor:the experience of the european pediatric soft tissue sarcoma study group (EpSSG)[J].Eur J Cancer, 2020, 127:123-129.DOI:10.1016/j.ejca.2019.12.021.
[23] Butrynski JE, D’adamo DR, Hornick JL, et al.Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor[J].N Engl J Med, 2010, 363(18):1727-1733.DOI:10.1056/NEJMoa1007056.
[24] Mosse YP, Voss SD, Lim MS, et al.Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor:A Children’s Oncology Group Study[J].J Clin Oncol, 2017, 35(28):3215-3221.DOI:10.1200/jco.2017.73.4830.
[25] Borczuk AC.Pulmonary neuroendocrine tumors[J].Surg Pathol Clin, 2020, 13(1):35-55.DOI:10.1016/j.path.2019.10.002.
[26] Rojas Y, Shi YX, Zhang W, et al.Primary malignant pulmonary tumors in children:a review of the national cancer data base[J].J Pediatr Surg, 2015, 50(6):1004-1008.DOI:10.1016/j.jpedsurg.2015.03.032.
[27] Petursdottir A, Sigurdardottir J, Fridriksson BM, et al.Pulmonary carcinoid tumours:incidence, histology and surgical outcome:a population-based study[J].Gen Thorac Cardiovasc Surg, 2020, 68(5):523-529.DOI:10.1007/s11748-019-01261-w.
[28] Caplin ME, Baudin E, Ferolla P, et al.Pulmonary neuroendocrine (carcinoid) tumors:european neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids[J].Ann Oncol, 2015, 26(8):1604-1620.DOI:10.1093/annonc/mdv041.
[29] Melosky B.Advanced typical and atypical carcinoid tumours of the lung:management recommendations[J].Curr Oncol, 2018, 25(Suppl 1):S86-S93.DOI:10.3747/co.25.3808.
[30] Kalhor N, Moran CA.Pulmonary mucoepidermoid carcinoma:diagnosis and treatment[J].Expert Rev Respir Med, 2018, 12(3):249-255.DOI:10.1080/17476348.2018.1428563.
[31] 张欣, 柏乾明, 姚茜岚, 等.原发性肺黏液表皮样癌MAML2基因重排、融合形式及临床病理学特征[J].中华病理学杂志, 2021, 50(8):891-898.DOI:10.3760/cma.j.cn.112151-20210421-00308.Zhang X, Bai QM, Yao QL, et al.MAML2 gene rearrangement, fusion patterns and clinicopathological characteristics in primary pulmonary mucoepidermoid carcinoma[J].Chinese Journal of Pathology, 2021, 50(8):891-898.DOI:10.3760/cma.j.cn.112151-20210421-00308.
[32] Li S, Zhang Z, Tang H, et al.Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma:a case report and literature review[J].Clin Respir J, 2017, 11(3):346-51.DOI:10.1111/crj.12343.
[33] Xi JJ, Jiang W, Lu SH, et al.Primary pulmonary mucoepidermoid carcinoma:an analysis of 21 cases[J].World J Surg Oncol, 2012, 10:232.DOI:10.1186/1477-7819-10-232.
[34] Dehner LP, Messinger YH, Schultz KA, et al.Pleuropulmonary Blastoma:Evolution of an Entity as an Entry into a Familial Tumor Predisposition Syndrome[J].Pediatr Dev Pathol, 2015, 18(6):504-511.DOI:10.2350/15-10-1732-oa.1.
[35] Mlika M, Anjum F, El Mezni F.Pleuropulmonary Blastoma[M].StatPearls.Treasure Island (FL).2021.
[36] Dishop MK, Kuruvilla S.Primary and metastatic lung tumors in the pediatric population:a review and 25-year experience at a large children’s hospital[J].Arch Pathol Lab Med, 2008, 132(7):1079-1103.DOI:10.5858/2008-132-1079-PAMLTI.
[37] Mon RA, Johnson KN, Ladino-Torres M, et al.Diagnostic accuracy of imaging studies in congenital lung malformations[J].Arch Dis Child Fetal Neonatal Ed, 2019, 104(4):F372-F377.DOI:10.1136/archdischild-2018-314979.
[38] Saez BJ, Pattillo SJ, Vuletin SJ.Pleuro-pulmonary blastoma presenting as a chest wall deformity:a case report[J].Rev Chil Pediatr, 2018, 89(2):231-235.DOI:10.4067/s0370-41062018000200231.
[39] Da M, Peng W, Mo X, et al.Comparison of efficacy between video-assisted thoracoscopic surgery and thoracotomy in children with mediastinal tumors:6-year experience[J].Ann Transl Med, 2019, 7(22):653.DOI:10.21037/atm.2019.10.81.
[40] Cohn SL, Pearson AD, London WB, et al.The international neuroblastoma risk group (INRG) classification system:an INRG task force report[J].J Clin Oncol, 2009, 27(2):289-97.DOI:10.1200/jco.2008.16.6785.
[41] Whittle SB, Smith V, Doherty E, et al.Overview and recent advances in the treatment of neuroblastoma[J].Expert Rev Anticancer Ther, 2017, 17(4):369-386.DOI:10.1080/14737140.2017.1285230.
[42] Zafar A, Wang W, Liu G, et al.Molecular targeting therapies for neuroblastoma:Progress and challenges[J].Med Res Rev, 2021, 41(2):961-1021.DOI:10.1002/med.21750.
[43] 左彤彤, 周卫萍.神经母细胞瘤的分子生物学特性和靶向药物临床研究进展[J].中国肿瘤临床, 2021, 48(8):426-431.DOI:10.3969/j.issn.1000-8179.2021.08.245.Zuo TT, Zhou WP.Research advances in molecular biology and targeted therapies of neuroblastoma[J].Chinese Journal of Clinical Oncology, 2021, 48(8):426-431.DOI:10.3969/j.issn.1000-8179.2021.08.245.
[44] Cairo MS, Beishuizen A.Childhood, adolescent and young adult non-Hodgkin lymphoma:current perspectives[J].Br J Haematol, 2019, 185(6):1021-1042.DOI:10.1111/bjh.15764.
[45] Mauz-Korholz C, Metzger ML, Kelly KM, et al.Pediatric Hodgkin Lymphoma[J].J Clin Oncol, 2015, 33(27):2975-2985.DOI:10.1200/jco.2014.59.4853.
[46] Mauz-Korholz C, Stroter N, Baumann J, et al.Pharmacotherapeutic management of pediatric lymphoma[J].Paediatr Drugs, 2018, 20(1):43-57.DOI:10.1007/s40272-017-0265-x.
[47] Mosbech CH, Rechnitzer C, Brok JS, et al.Recent advances in understanding the etiology and pathogenesis of pediatric germ cell tumors[J].J Pediatr Hematol Oncol, 2014, 36(4):263-270.DOI:10.1097/mph.0000000000000125.
[48] Kim J, Lee NH, Lee SH, et al.Prognostic factors in children with extracranial germ cell tumors treated with cisplatin-based chemotherapy[J].Korean J Pediatr, 2015, 58(10):386-391.DOI:10.3345/kjp.2015.58.10.386.
[49] Rescorla FJ.Pediatric germ cell tumors[J].Semin Pediatr Surg, 2012, 21(1):51-60.DOI:10.1053/j.sempedsurg.2011.10.005.
[50] Shaikh F, Murray MJ, Amatruda JF, et al.Paediatric extracranial germ-cell tumours[J].Lancet Oncol, 2016, 17(4):e149-e162.DOI:10.1016/s1470-2045(15)00545-8.
[51] Weil BR, Billmire DF.Management of germ cell tumors in pediatric patients[J].Surg Oncol Clin N Am, 2021, 30(2):325-338.DOI:10.1016/j.soc.2020.11.011.
[52] Simonelli M, Rosti G, Banna GL, et al.Intensified chemotherapy with stem-cell rescue in germ-cell tumors[J].Ann Oncol, 2012, 23(4):815-822.DOI:10.1093/annonc/mdr403.